First patient treated in Mapi Pharma's Phase IIa clinical trial of GA Depot for relapsing remitting multiple sclerosis (RRMS)
Mapi Pharma, 17 Dec 2014
Accessed on 23 Dec 2014 from http://www.mapi-pharma.com/first-patient-treated-in-mapi-pharmas-phase-iia-clinical-trial-of-ga-depot-for-relapsing-remitting-multiple-sclerosis-rrms/.